Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Mallinckrodt
McKinsey
AstraZeneca
Express Scripts

Last Updated: November 15, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Solanezumab

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Solanezumab?

Solanezumab is an investigational drug.

There have been 10 clinical trials for Solanezumab. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2009.

The most common disease conditions in clinical trials are Alzheimer Disease, Cognition Disorders, and Mild Cognitive Impairment. The leading clinical trial sponsors are Eli Lilly and Company, Avid Radiopharmaceuticals, and Alzheimer's Association.

Recent Clinical Trials for Solanezumab
TitleSponsorPhase
A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's DiseaseEli Lilly and CompanyPhase 3
A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)Eli Lilly and CompanyPhase 1
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory LossAlzheimer's Therapeutic Research InstitutePhase 3

See all Solanezumab clinical trials

Clinical Trial Summary for Solanezumab

Top disease conditions for Solanezumab
Top clinical trial sponsors for Solanezumab

See all Solanezumab clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Moodys
McKinsey
AstraZeneca
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.